Global Market Study on Pharmaceutical Glass Packaging: Sales of Syringes to Surpass Bottles by 2027


Pharmaceutical Glass Packaging Market
  • Published On : Feb-2018 |
  • Pages : 221 Pages |
  • Format :

Persistence Market Research (PMR) has lately published a new market research report on pharmaceutical glass packaging. The report delivers sharp insights on the chronological growth trajectory of the market along with the current and future growth prospects present in the market. The report delivers an exclusive understanding of the global market highlighting the regional and segment based aspects prominently. 

Pharmaceutical Glass Packaging Market: Synopsis

The report presents an entire summation of the market including an official abstract that draws out the center examples progressing in the market. It additionally converses on a couple of facets, for example, drivers, obstacles, and prospects that have been found in the global market. It also acquaints readers with data related to volume, value and expansion rate of the market from a growth point of view. With regards to market breakdown, each segment is examined and presented in the report. It also gives an evaluation in light of the market circumstance, and moreover presents a value chain analysis of the products and applications in concern. A year to year evolution of the market has similarly been presented in the report for the reader to be particularly aware of the changing landscape of the market.

Pharmaceutical Glass Packaging Market: Segment Overview  

Product Type

Application

Region

Material Type

  • Bottles
  • Syringes
  • Ampoules and Vials
  • Cartridges
  • Oral
  • Injectable
  • Nasal
  • Others (Topical, etc.)
  • North America
  • Latin America
  • Asia Pacific
  • Europe
  • MEA
  • Type I
  • Type II
  • Type III

Pharmaceutical Glass Packaging Market: Research Methodology

The report is the final product of the meticulous research work of the market experts using strong sources. The information introduced has been studied carefully by our industry experts. The data that has been presented here has been assembled from various tried and tested sources along with several other auxiliary sources. The market numbers have also been checked by the examiners and can be used to settle on key decisions and to formulate strategies. The analysts have used methods such as Porter’s Five Forces analysis and PESTLE (political, economic, social, technological, legal, and environmental) analysis to present a clear picture of the market to the readers.

Pharmaceutical Glass Packaging Market: Competitive Landscape

The market study conveys an immense outlook on the prevalent scene of the overall pharmaceutical glass packaging market. It also highlights the competition prevalent among the present vendors in the market and also puts weight on the future growth path of the market. The profile of the players relies upon a strong SWOT analysis sought down by company angle, product portfolio, strategies, finance related information, and year-to-year projections. The establishments have been explored minutely covering their key developments, improvements as well as mergers and acquisitions and contracts with other prominent associations.

Why should you invest in our reports?

The reports made by our industry analysts are credible and have been researched and authenticated from several primary and secondary resources. What makes us unique is the fact that along with presenting an analysis of the market’s historical and present scenario, we also present a forecast review of the market for the benefit of our readers. The presentation is unique in the form of various charts, tables, and diagrams. Every bit of information present in the market research report is unique. Expert opinions are also present in the report that can be directly used by the reader’s internal research team to freeze on future steps.

Syringes are expected to be the most attractive product type for incremental opportunities in the global pharmaceutical glass packaging market over the forecast period. Syringes are expected to witness an increase in market share in 2027 over 2017 by a herculean 670 basis points. Ampoules & vials are expected to create an incremental opportunity of over US$ 800.0 Mn expanding at a CAGR of 2.8% by the end of the forecast period.

pharmaceutical glass packaging market

Product Recalls in North America to Create Unstable Scenario

There have been product recalls recorded in North America for many glass ampoules, vials, and syringes due to glass breakages. Recalls were also because of several other syringe related causes. There was a recall of EPREX prefillable syringes because of leachable from the prefilled syringe rubber plunger. The leachable caused pure red cell aplasia in patients using the EPREX prefilled syringes. A syringe product recall was also due to the unequal silicone oil coating on the syringe barrel causing partial injection of the drug. Amgen recalled five lots of Enbrel pre-fillable syringes in October 2010. Johnson & Johnson recalled 70,000 antipsychotic drug prefilled syringes in February, 2011 owing to glass breakage.

Ampoules and Vials to be in High Demand in Latin America

Ampoules and vials are predominantly used in most of the countries in Latin America for packaging applications. Brazil and Mexico lead the Latin America market in terms of consumption. The pharmaceutical market in Brazil is growing at a higher rate which will boost the demand for pharmaceutical glass packaging products in the next few years. However, glass delamination is expected to act as a roadblock in the deployment of several products in the region. Glass delamination occurs from subsequent glass chipping and surface degradation which is observed visually as flakes within the drug product or solution.

Delamination is a prominent restraint observed in the pharmaceutical glass packaging market which needs to be addressed for long-term sustainability of the glass packaging products in the pharmaceutical industry. Products such as COC/COP based ampoules, vials, and syringes are expected to outgrow other pharmaceutical glass packaging products. This is primarily because polymer based packaging products offer high delamination resistance, longer shelf life, and good chemical resistance. Moreover, the polymer based products are cheaper in comparison to their glass counterparts.           

New Ampoules and Syringes to be Introduced in Asia Pacific

New therapeutic drugs are being approved in the Asia Pacific region in order to be administered in ampoules and prefilled syringes. With rapid advancements in the biologics and biosimilars market, the demand for ampoules, vials, and prefilled syringes is expected to spur in the coming years. More novel therapeutic drugs are being approved to be administered in ampoules and prefilled syringes as companies in the region are focusing on enhancing product development.

Currently, over 60 types of parenteral drugs and vaccines are being sold in the form of prefilled syringes. Common drug classes which are injectable and are available in prefilled syringes include insulin, interferon, mono clonal antibodies, G-CSFs, erythropoietin, blood stimulants and other vaccines. Other additional new therapeutic drugs are being approved to be administered in the prefilled syringes form. Patent expirations of several biologics has led to the introduction of biosimilars in the market. This is likely to boost the adoption of ampoules, vials and prefilled syringes in the Asia Pacific region.

Company Profiles
  • Schott AG
  • Gerresheimer AG
  • Becton, Dickinson and Company
  • Owens-Illinois, Inc.
  • Ardagh Group S.A.
  • Nipro Corporation
  • West Pharmaceutical Services, Inc.
  • Stevanato Group (Ompi)
  • O.Berk Company, LLC
  • ?i?ecam Group
  • DWK Life Sciences GmbH
  • Beatson Clark Ltd.
  • Piramal Glass Limited
  • Acme Vial and Glass Company, LLC
  • Amposan S.A.
  • SGD Pharma
  • Hindusthan National Glass & Industries Limited
  • Shandong Pharmaceutical Glass Co., Ltd.
  • Bormioli Pharma Srl
  • Agrado S.A.
  • Others.
Back To Top